and 1.0 mg kg -1 , respectively. The repeatability expressed as the average difference between results of duplicate measurements was 5.9 % at the concentration level of 1 % (concentrate), 7.1 % at the concentration level of 1 g kg -1 (premix), and 11 % with the feed containing maduramicin with the nominal concentration of 5 mg kg -1 and feed spiked at the concentration level of 1 mg kg -1 . The relative standard deviation for the within-laboratory reproducibility (RSD W ) was 9.2 %, 16 %, 18 %, and 17 % at the concentration levels of 1 %, 1 g kg -1 , 5 mg kg -1 , and 1 mg kg -1 , respectively. The measurement uncertainties were ±0.2 %, ± 0.3 g kg -1 , ±1.9 mg kg -1 , and ±0.3 mg kg -1 at the same concentration levels, respectively. . In view of the absence of suitable regulations, it seems to be a reasonable starting point, although it provides rules for analytical methods used for the determination of residues in products of animal origin. The purpose of the present work is to report the performance characteristics of the procedure and to provide the comparison with data presented by De Jong 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (2004) . Nevertheless, the procedure might be an alternative for the determination of maduramicin avoiding the use of post-column derivatisation device.
Materials and methods

Apparatus
Universal laboratory oven (Memmert, Schwabach, Germany) was used for drying samples and the linear shaker IKA HS 501 digital (IKA Labortechnik, Staufen, Germany) was used for the extraction. Measurements were performed with an HPLC system Waters Alliance 2690
(Waters, Milford, MA, USA) equipped with a computer with a program Millennium for the system control and data processing, a column Luna C18, 5 µm, 150 x 4.6 (Phenomenex, Torrance, CA, USA), and UV/VIS detector Waters 2487. The mobile phase flow rate was 3 mL min -1 , the injection volume 20 µL and the column was kept at ambient temperature. The detection was carried out at λ = 254 nm.
Samples
The validation of the procedure was performed with the samples of a concentrate, a premix and a feed containing 1 %, 1 g kg -1 , and 5 mg kg -1 of maduramicin, respectively and samples of blank feeds. The concentrate was produced by Alpharma Animal Health (Fordingbridge, UK). The premix, intended for broilers and the feed for turkeys containing maduramicin were produced by Lek Veterina (Lipovci, Slovenia). As blank feeds, two commercially available finishers for broilers and two commercially available feedingstuffs for laying hens produced by Slovene feed plants were used. They were spiked with maduramicin prior to the extraction using a standard solution. The selected volume of a standard solution was applied to a 
Analytical procedure
A modified procedure of Gliddon et al. (1988) and Markantonatos (1988) was used. A weighed portion of a sample (20.0 g of a ground feed sample, 2.0 g of a premix or 2.0 g of a concentrate) was extracted with 100 mL of acetonitrile for 1 hour using a linear shaker. Feed µL trichloroacetic acid solution were added and the mixture was stirred for 10 seconds. The mixture was transferred promptly onto the SPE column. The column was washed twice with two 5.0 mL portions of acetonitrile. All the liquid from the column was discarded. The analyte was eluted from the column with 5.0 mL of acetonitrile-water mixture. Maduramicin was determined by an HPLC method with UV detection under conditions described above.
The working standard solutions used for the preparation of the calibration curve were derivatised with dansylhydrazine and passed the SPE column in the same way as samples.
Validation procedure
For the linearity test as well as for the determination of LOD and LOQ, working standard solutions of maduramicin with concentrations from 0.1 µg mL -1 to 2 µg mL -1 , which corresponds to the maduramicin content in feeds from 0.5 mg kg -1 to 10 mg kg -1 , were prepared and HPLC measurements were performed. The identity of the analyte was examined by co-chromatography. Chromatographic measurements of a sample extract, obtained from a feed sample containing maduramicin and the sample extract with an addition of a standard solution of maduramicin were performed. For the within-laboratory reproducibility test, the concentrate, the premix, and the feed containing maduramicin were analysed by three analysts in three consecutive days. Each analyst prepared each sample in duplicates every day. Blank feeds were spiked with maduramicin at the concentration level of 1 mg kg -1 and prepared in duplicates as well (each of two finishers for broilers and one of two feedingstuffs for laying hens were prepared twice, and one feedingstuffs for laying hens was prepared three times). The design of experiments is presented in Table 1 . The results of these experiments were used also for the repeatability test, for the evaluation of measurement uncertainty and for the determination of the recovery. For the determination of the recovery, blank samples were spiked also at the concentration level of 5 mg kg -1 .
Statistical procedures
In the present study, LOD was defined as a concentration giving a signal ) 
Results and discussion
The equation describing the calibration curve, constructed from six points in the range from 0.1 µg mL -1 to 2 µg mL -1 , which corresponds to the maduramicin content in feeds from 0.5 mg kg -1 to 10 mg kg -1 , was y = 6917x -2.4, where y is the peak area expressed in µVs and x is the concentration of maduramicin expressed in µg mL Figure 1 , it is evident that only the height of the maduramicin peak was enhanced by the addition of the maduramicin standard, hence the peak can be assigned to maduramicin.
In The repeatability of the procedure was evaluated by means of differences between results of duplicate measurements. The average differences were 5.9 % at the concentration level of 1 % (concentrate), 7.1 % at the concentration level of 1 g kg -1 (premix), and 11 % with the feed containing maduramicin with the nominal concentration of 5 mg kg -1 and feed spiked at the concentration level of 1 mg kg -1 . They are lower than 15 % relative to the higher value, taken as the maximum permitted difference as mentioned above, thus they are deemed acceptable. The measurement uncertainties determined at the concentration levels of 1 % (concentrate), 1 g kg -1 (premix), 5 mg kg -1 (feed) and 1 mg kg -1 (blank feed spiked with maduramicin) were ±0.2 %, ±0.3 g kg -1 , ±1.9 mg kg -1 , and ±0.3 mg kg -1 , respectively. They will be reported along the analytical results and taken into account for checking the compliance of samples. As mentioned above, the measurement uncertainties were calculated from the within-laboratory reproducibility. Since the mean recovery was close to 100 % and results of routine analysis 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
